Legal
Filter News
Found 7,543 articles
-
And now, this
6/20/2018
There are no words to describe and acknowledge this historic moment in Canada.
-
Following AbbVie Lawsuit, Government Scrutinizes Industry-Provided Drug Educational Support Services
9/21/2018
A federal investigation is underway into whether or not the nursing and other medical services provided by some pharmaceutical companies to doctor’s offices actually violate the law due to serving an illegal commercial service. -
As federal lawmakers continue to wrangle over legislation to help curb the opioid crisis in the United States, the House of Representatives is showing some division over the costs that some pharmaceutical companies may have to pay for Medicare coverage.
-
AARP Pushes Back on PhRMA's Attempts to Change Medicare Part D Doughnut Hole Deal
9/21/2018
AARP Executive Vice President and Chief Advocacy & Engagement Officer Nancy LeaMond released the following statement in response to lobbying efforts by PhRMA to change the Medicare Part D doughnut hole deal
-
Delaware Court of Chancery Grants Petition Filed by MabVax Therapeutics
9/21/2018
MabVax Therapeutics Holdings, Inc. (OTC: MBVX), a clinical-stage biotechnology company with a fully human antibody discovery platform focused on the development of antibody-based products to address unmet medical needs, announces today that the Court of Chancery of the State of Delaware (the "Court") on September 20, 2018, granted the Company's Verified Petition for Relief Under 8 Del.
-
Willowbrook Families File Lawsuit Against Sterigenics for Their Ethylene Oxide Emissions
9/21/2018
Power Rogers & Smith attorneys Todd A. Smith and Brian LaCien are representing Willowbrook families who filed a class action lawsuit against Sterigenics International LLC and GTCR LLC
-
Purus Labs Recalls MyoWhey due to Undeclared Allergens
9/21/2018
PURUS LABS ISSUES ALLERGY ALERT ON UNDECLARED MILK AND SOY IN MYOWHEY
-
5G Faces its Biggest Obstacle: Health Impacts
9/20/2018
Hundreds of Independent Peer-Reviewed Studies Show Positive Correlation Between RF Microwave Radiation Exposure and Biological Damage
-
California Enacts First-In-Nation Law Requiring Doctors To Tell Patients When They Are On Probation, Says Consumer Watchdog
9/20/2018
Revelations by Women Sexually Assaulted By Their Doctors Spurred Transparency
-
AbbVie Investigation: Bernstein Liebhard LLP Announces Investigation Of AbbVie Inc. - ABBV
9/20/2018
Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, is investigating potential securities fraud claims on behalf of shareholders of AbbVie Inc. ("AbbVie" or the "Company") (NYSE: ABBV) resulting from allegations that AbbVie and/or its executives may have issued materially misleading business information to the investing public.
-
American Diabetes Association® Celebrates Culmination of Two Decades of Advocacy on Behalf of Commercial Drivers with Insulin-Treated Diabetes Following Final Rule
9/20/2018
The American Diabetes Association (ADA) applauds the U.S. Department of Transportation, Federal Motor Carrier Safety Administration (FMCSA) for its new rule permitting individuals with insulin-treated diabetes to be certified to operate commercial motor vehicles in interstate commerce.
-
Senate's 'Surprise Billing' Proposal Attacks Independent Physicians, Benefits Insurers, States the Association of American Physicians and Surgeons (AAPS)
9/20/2018
A bipartisan group of senators led by Bill Cassidy (R-La.) is proposing a bill that would impose price controls on independent ("out of network") physicians, under the guise of preventing outrageous "surprise bills" and medical bankruptcies, states the Association of American Physicians and Surgeons (AAPS).
-
Bernstein Liebhard LLP Partner Named to Plaintiffs' Executive Committee for Federal Onglyza Heart Failure Lawsuits
9/20/2018
Daniel C. Burke, a partner at Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices, has been appointed to the Plaintiffs' Executive Committee in the multidistrict litigation established earlier this year for all federally-filed product liability lawsuits involving Onglyza and Kombiglyze XR.
-
SevenSaoi Capital Delivers Letter to the Board of PDL BioPharma
9/20/2018
Expresses Serious Concerns Regarding PDL's Misguided Acquisition Strategy, Which Has Destroyed Shareholder Value
-
Robert F. Kennedy, Jr. Demands the Office of the Inspector General and Congress Investigate Department of Justice for Fraud and Obstruction of Justice
9/20/2018
Robert F. Kennedy Jr., Chairman of Children's Health Defense (CHD), and Rolf Hazlehurst, parent of a vaccine-injured child, petitioned the Department of Justice (DOJ) Office of Inspector General (OIG), and the Senate and House Judiciary Committees today to investigate actions taken by federal personnel during the "Vaccine Court" Omnibus Autism Proceedings (OAP).
-
Amicus Therapeutics Acquires Gene Therapy Portfolio of Ten Clinical and Pre-Clinical Stage AAV Programs in Neurologic Lysosomal Storage Disorders
9/20/2018
License with Nationwide Children’s Hospital (NCH) through the Acquisition of Celenex (NCH Spinout)
-
Emergex Enters into MoU with Brazil’s Fiocruz to Develop Novel Vaccines Against Viral Diseases
9/20/2018
Emergex Vaccines Holding Limited today announces that it has signed a Memorandum of Understanding (MoU) with Brazil-based Oswaldo Cruz Foundation ‘Fiocruz’ for the development of viral vaccines.
-
Applied DNA Subsidiary, LineaRx, Inc. Signs Joint Development Agreement with Takis and Evvivax to Develop Linear-DNA Based Anti-Cancer Vaccines
9/20/2018
Collaboration Seeks to Develop PCR-produced Linear DNA as a Safer Expression Vector for Vaccines
-
Illinois-based AbbVie is under fire from California’s Insurance Commissioner over allegations of a kickback scheme to support sales of blockbuster rheumatoid arthritis treatment Humira in the state.
-
Clovis Oncology will pay more than $20 million in penalties to settle charges that Chief Executive Officer Patrick Mahaffy and its former Chief Financial Officer Erle Mast misleading investors about the company’s lung cancer treatment leading up to a public offering of stock.